申请人:Array Biopharma Inc.
公开号:US20200030311A1
公开(公告)日:2020-01-30
Provided herein are compounds of the Formula I:
or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X
1
, X
2
, X
3
, X
4
, Ring D, E, R
a
, R
b
, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.